carbamates has been researched along with Microsatellite Instability in 3 studies
Microsatellite Instability: The occurrence of highly polymorphic mono- and dinucleotide MICROSATELLITE REPEATS in somatic cells. It is a form of genome instability associated with defects in DNA MISMATCH REPAIR.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Two new treatments have recently become standard care for patients with metastatic colorectal cancer (mCRC): encorafenib (BRAF inhibitor) associated with cetuximab (anti-EGFR) in the second or third line of chemotherapy for BRAF V600E tumors, and pembrolizumab (an anti PD-1 immune checkpoint inhibitor) for tumors harboring microsatellite instability (MSI)-high and/or deficient mismatch repair (dMMR)." | 8.12 | Upfront progression under pembrolizumab followed by a complete response after encorafenib and cetuximab treatment in BRAF V600E-mutated and microsatellite unstable metastatic colorectal cancer patient: A case report. ( Broudin, C; Gallois, C; Garinet, S; Karoui, M; Sabouret, A; Taieb, J; Zaanan, A, 2022) |
| "Two new treatments have recently become standard care for patients with metastatic colorectal cancer (mCRC): encorafenib (BRAF inhibitor) associated with cetuximab (anti-EGFR) in the second or third line of chemotherapy for BRAF V600E tumors, and pembrolizumab (an anti PD-1 immune checkpoint inhibitor) for tumors harboring microsatellite instability (MSI)-high and/or deficient mismatch repair (dMMR)." | 4.12 | Upfront progression under pembrolizumab followed by a complete response after encorafenib and cetuximab treatment in BRAF V600E-mutated and microsatellite unstable metastatic colorectal cancer patient: A case report. ( Broudin, C; Gallois, C; Garinet, S; Karoui, M; Sabouret, A; Taieb, J; Zaanan, A, 2022) |
| "Metastatic colorectal cancer (mCRC) is a heterogeneous disease with distinct molecular subtypes." | 1.72 | Retrospective Analysis of Treatment Pathways in Patients With BRAF ( Agocs, GR; Bastian, S; Eisterer, W; Fenchel, K; Fritsch, R; Fuxius, S; Gerger, A; Greil, R; Koeberle, D; Maas, C; Modest, DP; Reichenbach, F; Sanoyan, DA; Schwager, M; Uhlig, J; VON DER Heyde, E; Weide, R; Welslau, M, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Gallois, C | 1 |
| Taieb, J | 1 |
| Sabouret, A | 1 |
| Broudin, C | 1 |
| Karoui, M | 1 |
| Garinet, S | 1 |
| Zaanan, A | 1 |
| Gerger, A | 1 |
| Eisterer, W | 1 |
| Fuxius, S | 1 |
| Bastian, S | 1 |
| Koeberle, D | 1 |
| Welslau, M | 1 |
| Sanoyan, DA | 1 |
| Maas, C | 1 |
| Uhlig, J | 1 |
| Fenchel, K | 1 |
| Greil, R | 1 |
| VON DER Heyde, E | 1 |
| Agocs, GR | 1 |
| Weide, R | 1 |
| Schwager, M | 1 |
| Reichenbach, F | 1 |
| Modest, DP | 1 |
| Fritsch, R | 1 |
| Mishra, PK | 1 |
| Bunkar, N | 1 |
| Raghuram, GV | 1 |
| Khare, NK | 1 |
| Pathak, N | 1 |
| Bhargava, A | 1 |
3 other studies available for carbamates and Microsatellite Instability
| Article | Year |
|---|---|
Upfront progression under pembrolizumab followed by a complete response after encorafenib and cetuximab treatment in BRAF V600E-mutated and microsatellite unstable metastatic colorectal cancer patient: A case report.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Carbamates; Cetuximab; Colon; Colorectal N | 2022 |
Retrospective Analysis of Treatment Pathways in Patients With BRAF
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Carbamates; Cetuximab; Color | 2022 |
Epigenetic dimension of oxygen radical injury in spermatogonial epithelial cells.
Topics: Animals; Antioxidants; Carbamates; Cell Line; Cell Nucleus; DNA Damage; DNA, Mitochondrial; Epigenes | 2015 |